RxDB
ICD-10-PCS Codes Browse (Tables)

ICD-10 PCS – Browse (Tables)

Code Title
– Top Categories
3 Administration
3E Physiological Systems and Anatomical Regions
3E0 Introduction Administration, Physiological Systems and Anatomical Regions, Introduction
3E0Y Pericardial Cavity
3E0Y3 Percutaneous
3E0Y30 Antineoplastic
3E0Y304 Liquid Brachytherapy Radioisotope Introduction of Liquid Brachytherapy Radioisotope into Pericardial Cavity, Percutaneous Approach
3E0Y305 Other Antineoplastic Introduction of Other Antineoplastic into Pericardial Cavity, Percutaneous Approach
3E0Y30M Monoclonal Antibody Introduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Percutaneous Approach
3E0Y32 Anti-infective
3E0Y328 Oxazolidinones Introduction of Oxazolidinones into Pericardial Cavity, Percutaneous Approach
3E0Y329 Other Anti-infective Introduction of Other Anti-infective into Pericardial Cavity, Percutaneous Approach
3E0Y33 Anti-inflammatory
3E0Y33Z No Qualifier Introduction of Anti-inflammatory into Pericardial Cavity, Percutaneous Approach
3E0Y36 Nutritional Substance
3E0Y36Z No Qualifier Introduction of Nutritional Substance into Pericardial Cavity, Percutaneous Approach
3E0Y37 Electrolytic and Water Balance Substance
3E0Y37Z No Qualifier Introduction of Electrolytic and Water Balance Substance into Pericardial Cavity, Percutaneous Approach
3E0Y3B Anesthetic Agent
3E0Y3BZ No Qualifier Introduction of Anesthetic Agent into Pericardial Cavity, Percutaneous Approach
3E0Y3G Other Therapeutic Substance
3E0Y3GC Other Substance Introduction of Other Therapeutic Substance into Pericardial Cavity, Percutaneous Approach
3E0Y3H Radioactive Substance
3E0Y3HZ No Qualifier Introduction of Radioactive Substance into Pericardial Cavity, Percutaneous Approach
3E0Y3K Other Diagnostic Substance
3E0Y3KZ No Qualifier Introduction of Other Diagnostic Substance into Pericardial Cavity, Percutaneous Approach
3E0Y3N Analgesics, Hypnotics, Sedatives
3E0Y3NZ No Qualifier Introduction of Analgesics, Hypnotics, Sedatives into Pericardial Cavity, Percutaneous Approach
3E0Y3S Gas
3E0Y3SF Other Gas Introduction of Other Gas into Pericardial Cavity, Percutaneous Approach
3E0Y3T Destructive Agent
3E0Y3TZ No Qualifier Introduction of Destructive Agent into Pericardial Cavity, Percutaneous Approach
3E0Y4 Percutaneous Endoscopic
3E0Y4G Other Therapeutic Substance
3E0Y4GC Other Substance Introduction of Other Therapeutic Substance into Pericardial Cavity, Percutaneous Endoscopic Approach
3E0Y7 Via Natural or Artificial Opening
3E0Y70 Antineoplastic
3E0Y704 Liquid Brachytherapy Radioisotope Introduction of Liquid Brachytherapy Radioisotope into Pericardial Cavity, Via Natural or Artificial Opening
3E0Y705 Other Antineoplastic Introduction of Other Antineoplastic into Pericardial Cavity, Via Natural or Artificial Opening
3E0Y70M Monoclonal Antibody Introduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Via Natural or Artificial Opening
3E0Y7S Gas
3E0Y7SF Other Gas Introduction of Other Gas into Pericardial Cavity, Via Natural or Artificial Opening